SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Hepatology Consultation — Joe Frazier

PatientJoe Frazier
Date of birth1962-01-12
IdentifiersMRN HR-BX004-SYN; SSN (made up) 000-04-5590
Document date2026-03-02
AuthorAnjali Deshpande, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

High FIB-4 (3.43) with a mildly raised AST and low platelets at the yearly liver check in a 64-year-old man with type 2 diabetes, hypertension, low HDL, high triglycerides and obesity, who drinks little. Please stage his liver disease with elastography and advise on surveillance and treatment. [S]

Urgency: Within two weeks, with elastography and an ultrasound the same day. [S]

Questions for the consultant:

History of Present Illness

Mr. Frazier, a 64-year-old former professional boxer, is seen at the request of Dr. Whitfield for a FIB-4 of 3.43 found at his yearly diabetes check. He feels well and has had no jaundice, abdominal or leg swelling, black stools, vomiting of blood or confusion. He drinks one or two beers on some weekends and has never drunk heavily. He has had diabetes for about twelve years and high blood pressure for many years. He has never had a blood transfusion or used injected drugs. He wants to keep working at his gym. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1000 mg oral tablet, one tablet twice daily with meals; taken for yearsOne tablet twice daily with mealsOral route2026-02-16activeS
Lisinopril 20 mg oral tablet, one tablet daily; taken for yearsOne tablet dailyOral route2026-02-16activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-02-16activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-02 to 2026-04-13completedS
Semaglutide pen (0.25 mg or 0.5 mg per dose), 0.25 mg under the skin once weekly for four weeks, then 0.5 mg once weekly0.25 mg weekly for four weeks, then 0.5 mg weeklySubcutaneous route2026-03-02 to 2026-05-18completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes with hyperglycemia, about twelve years' duration, A1c 8.4% on metformin; synthetic modern episode linked to his publicly reported diabetesactiveconfirmed E11.65S — Synthetic modern diagnosis; diabetes was reported publicly during his life, but its duration and treatment here are synthetic.
Hypertension above goal on lisinopril (152/92 mmHg in the clinic); synthetic modern episode linked to his publicly reported high blood pressureactiveconfirmed I10S — Synthetic modern diagnosis; high blood pressure was reported publicly during his life.
Raised AST (48 U/L) with mildly low platelets (138) and a FIB-4 score of 3.43 at the yearly liver check, to be evaluatedresolvedconfirmed R74.01S — Synthetic presenting finding, superseded at the two-week visit by the elastography and ultrasound diagnosis.
Metabolic dysfunction-associated steatotic liver disease (MASLD): steatosis on elastography (controlled attenuation parameter 318 dB/m) and ultrasound, with diabetes, obesity, low HDL and high triglycerides, and little alcoholactiveconfirmed K76.0S — Synthetic modern diagnosis. Not part of the public record of his life; chosen to teach surveillance.
Compensated cirrhosis (compensated advanced chronic liver disease) from MASLD: liver stiffness 17.6 kPa, platelets 138, nodular liver surface and a spleen of 13.4 cm on ultrasound; no ascites, encephalopathy, bleeding or jaundice; Child-Pugh Aactiveconfirmed K74.69S — Synthetic modern diagnosis. Not part of the public record of his life; the liver cancer diagnosed three years later in the true frame does not appear in the modern episode.
Hyperlipidemia: LDL 132 mg/dL, HDL 38 and triglycerides 210, not on a statinactiveconfirmed E78.5S — Synthetic laboratory finding.
Obesity, class 1 (BMI 31.4)activeconfirmed E66.811S — Synthetic finding; described without stigma.
Reduced vision in the left eye since a cataract found at 20 (counting fingers at 1 meter); right eye 20/30activeconfirmed H54.62S — Synthetic modern measurement anchored to the documented cataract in his left eye.

Physical Exam

Vital signs recorded on 2026-03-02; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 148/90, pulse 74; BMI 31.3
AbdomenLiver edge firm at the costal margin; spleen tip not felt; no ascites
SkinNo jaundice, spider angiomas or palmar erythema
NeurologicalNo asterixis

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Liver stiffness by US.transient elastography17.6kPaBelow 8 kPa makes advanced fibrosis unlikely; 15 kPa or higher is consistent with compensated advanced chronic liver diseaseHighS
2026-03-02INR in Platelet poor plasma by Coagulation assay1.1{INR}0.8-1.2NormalS
2026-03-02Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma4.2ng/mL<=8.3 ng/mLNormalS

Assessment

Data reviewed: Dr. Whitfield's intake note and results: AST 48, ALT 42 U/L, alkaline phosphatase 96, albumin 4.0 g/dL, bilirubin 0.9 mg/dL, platelets 138, creatinine 1.08 mg/dL, FIB-4 3.43. Today: transient elastography with a median liver stiffness of 17.6 kPa (interquartile range 14%) and a controlled attenuation parameter of 318 dB/m; ultrasound with a coarse, echogenic, mildly nodular liver, a spleen of 13.4 cm, a patent portal vein, no ascites and no focal lesion; INR 1.1; AFP 4.2 ng/mL. Hepatitis B surface antigen, core antibody and surface antibody negative; hepatitis A antibody negative; hepatitis C antibody and HIV nonreactive; ferritin and transferrin saturation normal; antinuclear and smooth muscle antibodies negative. [S]

Plan of Treatment